Accès gratuit
| Numéro |
Biologie Aujourd'hui
Volume 206, Numéro 4, 2012
Journée Claude Bernard 2011
|
|
|---|---|---|
| Page(s) | 237 - 248 | |
| DOI | https://doi.org/10.1051/jbio/2012025 | |
| Publié en ligne | 19 février 2013 | |
- Al Khouri F.H., Roblot-Treupel L., Devissaguet J.P., Puisieux F., An original procedure for preparing nanocapsules of polyalkylcyanoacrylates for interfacial polymerization. Pharm Acta Helv, 1986, 61, 274−281. [PubMed] [Google Scholar]
- Arias J.L., Reddy L.H., Othman M., Gillet B., Desmaële D., Zouhiri F., Dosio F., Gref R., Couvreur P., Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. ACS Nano, 2011, 22, 1513−1521. [CrossRef] [Google Scholar]
- Barraud L., Merle P., Soma E., Lefrançois L., Guerret S., Chevallier M., Dubernet C., Couvreur P., Trépo C., Vitvitski L., Increase of doxorubicin sensitivity by doxorubicin loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepathology, 2005, 42, 736−743. [CrossRef] [Google Scholar]
- Bekkara-Aounallah F., Gref R., Othman M., Reddy L.H., Pili B., Allain V., Bourgaux C., Hillaireau H., Lepêtre-Mouelhi S., Desmaële D., Nicolas J., Chafi N., Couvreur P., Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues. Adv Funct Materials, 2008, 18, 3715−3725. [CrossRef] [Google Scholar]
- Bildstein L., Dubernet C., Marsaud V., Chacun H., Nicolas V., Gueutin C., Sarasin A., Bénech H., Lepêtre-Mouelhi S., Desmaële D., Couvreur P., Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: An original drug delivery pathway. J Control Rel, 2010, 147, 163−170. [CrossRef] [Google Scholar]
- Brigger I., Morizet J., Aubert G., Chacun H., Terrier-Lacombe M.J., Couvreur P., Vassal G., Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Pharmacol Exp Ther, 2002, 303, 928−936. [CrossRef] [PubMed] [Google Scholar]
- Calvo P., Gouritin B., Villarroya H., Eclancher F., Giannavola C., Klein C., Andreux J.P., Couvreur P., Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Eur J Neurosci, 2002, 15, 1317−1326. [CrossRef] [PubMed] [Google Scholar]
- Chiannilkulchai N., Ammoury B., Caillou J.P., Devissaguet P., Couvreur P., Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M5076 metastasis-bearing mice. Cancer Chemother Pharmacol, 1990, 26, 122−126. [CrossRef] [PubMed] [Google Scholar]
- Colin de Verdière A., Dubernet C., Némati F., Soma E., Appel M., Ferté J., Bernard S., Puisieux F., Couvreur P., Reversion of the multidrug resistance with polyalkylcyanoacrylate nanoparticles: mechanism of action. Brit J Cancer, 1997, 76, 198−205. [CrossRef] [Google Scholar]
- Couvreur P., « Les nanotechnologies peuvent-elles contribuer à traiter des maladies sévères ? » Leçon inaugurale du Collège de France, Fayard 2010. [Google Scholar]
- Couvreur P., Tulkens P., Roland M., Trouet A., Speiser P., Nanocapsules: a new type of lysosomotropic carrier., FEBS Lett, 1977, 84, 323−326. [CrossRef] [PubMed] [Google Scholar]
- Couvreur P., Stella B., Reddy L.H., Hillaireau H., Dubernet C., Desmaële D., Lepêtre-Mouelhi S., Rocco F., Dereuddre-Bosquet N., Clayette P., Rosilio V., Marsaud V., Renoir M., Cattel L., Squalenoyl nanomedicines as potential therapeutics. Nano Lett, 2006, 6, 2544−2548. [CrossRef] [PubMed] [Google Scholar]
- Couvreur P., Reddy L.H., Mangenot S., Poupaert J.H., Desmaële D., Lepêtre-Mouelhi S., Pili B., Bourgaux C., Amenitsch H., Ollivon M., Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. Small, 2008, 42, 247−53. [CrossRef] [Google Scholar]
- de Martimprey H., Bertrand J.R., Fusco A., Santoro M., Couvreur P., Vauthier C., Malvy C., siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucl Ac Res, 2008, 36, 1093−1094. [CrossRef] [Google Scholar]
- Gabizon A.A., Barenholz Y., Bialer M., Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res, 1993, 10, 703−708. [CrossRef] [PubMed] [Google Scholar]
- Gregoriadis G., Leathwood P.D., Ryman B.E., Enzyme entrapment in liposomes. FEBS Lett, 1971, 14, 95−99. [CrossRef] [PubMed] [Google Scholar]
- Hillaireau H., Couvreur P., Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci, 2009, 66, 2873−2896. [CrossRef] [PubMed] [Google Scholar]
- Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., Eubank J.F., Heurtaux D., Clayette P., Kreuz C., Chang J.S., Hwang Y.K., Marsaud V., Bories P.N., Cynober L., Gil S., Férey G., Couvreur P., Gref R., Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nature Mater, 2010, 9, 172−178. [CrossRef] [Google Scholar]
- Karatas H., Aktas Y., Gursoy-Ozdemir Y., Bodur E., Yemisci M., Caban S., Vural A., Pinarbasli O., Capan Y., Fernandez-Megia E., Novoa-Carballal R., Riguera R., Andrieux K., Couvreur P., Dalkara T., A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection. J Neurosci, 2009, 29, 13761−13769. [CrossRef] [PubMed] [Google Scholar]
- Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., Nishio K., Matsumura Y., Kataoka K., Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res, 2003, 63, 8977−8983. [PubMed] [Google Scholar]
- Mullard A., 2011 FDA drug approvals. Nat Rev Drug Discov, 2012, 11, 91. [CrossRef] [PubMed] [Google Scholar]
- Peracchia M.T., Harnisch S., Pinto-Alphandary H., Gulik A., Dedieu J.C., Desmaële D., d’Angelo J., Müller R.H., Couvreur P., Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials, 1999, 20, 14, 1269 − 1275. [CrossRef] [Google Scholar]
- Reddy L.H., Marque P.E., Dubernet C., Lepêtre-Mouelhi S., Dësmaele D., Couvreur P., Preclinical toxicology (sub-acute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine. J Pharm Exp Ther, 2008, 325, 484−490. [CrossRef] [Google Scholar]
- Reddy L.H., Renoir J.M., Marsaud V., Lepêtre-Mouelhi S., Dësmaele D., Couvreur P., Anticancer efficacy of squalenoyl Gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. Mol Pharm, 6, 2009, 1526−1535. [CrossRef] [PubMed] [Google Scholar]
- Scatton B., Le processus de découverte du médicament dans l’industrie pharmaceutique. J Soc Biol, 2009, 203, 249−269. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Sonvico F., Mornet S., Vasseur S., Dubernet C., Jaillard D., Degrouard J., Hoebeke J., Duguet E., Colombo P., Couvreur P., Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem, 2005, 16, 1181−1188. [CrossRef] [PubMed] [Google Scholar]
- Torchilin V., Multifunctional nanocarriers. Adv Drug Del Rev, 2006, 58, 1532−1555. [CrossRef] [Google Scholar]
- Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim Biophys Acta, 1992, 1105, 193 − 200. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.